To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP (clinicaltrials.gov) - Aug 12, 2026 - P2 | N=94 | Terminated | Sponsor: Immunovant Sciences GmbH | N=277 ➔ 94 | Trial completion date: Jan 2027 ➔ Jul 2026 | Active, not recruiting ➔ Terminated | Trial primary completion date: Jan 2026 ➔ Jul 2026; Sponsor Decision
Enrollment change • Trial completion date • Trial primary completion date • Trial termination
|